|
CAS番号. | 33626-08-3 |
化学名: | |
别名: | |
英語化学名: | 4'-Methoxyresveratrol |
英語别名: | 4'-Methoxyresveratrol;4'-Methoxy resveratol;4'-O-Methylresveratrol;(E)-3,5-Dihydroxy-4'-methoxystilbene;(E)-5-(4-Methoxystyryl)benzene-1,3-diol |
CBNumber: | CB62489580 |
分子式: | C15H14O3 |
分子量: | 242.273 |
MOL File: | 33626-08-3.mol |
|
|
|
|
4'-Methoxyresveratrol 物理性質 |
|
4'-Methoxyresveratrol 化学特性,用途語,生産方法 |
使用
4'-O-Methylresveratrol is an impurity of resveratrol (R150000), an anticancer agent that has been shown to inhibit events associated with tumor initiation, promotion and progression. |
|
|
4'-Methoxyresveratrol 上流と下流の製品情報 |
原材料
|
準備製品
|
4'-Methoxyresveratrol 生産企業 Global( 26)Suppliers |
名前 | 電話番号 | ファックス番号 | 電子メール | 国籍 | 製品カタログ | 優位度 |
J & K SCIENTIFIC LTD.
| -- | -- | jkinfo@jkchemical.com;market3@jkchemical.com | CHINA |
96847
|
76
|
Secco work (Beijing) chemical technology co., LTD
| 010-69755668; 62507480 | 010-69755668 | 1139670422@qq.com | CHINA |
3551
|
54
|
XiaoGan ShenYuan ChemPharm co,ltd
| Tell:86-712-2580635 Mobile:15527768850、 18986454762 | 86-712-2580625 QQ:1623551145 | sales02@farchem.com | CHINA |
9844
|
52
|
Chengdu XiYa Chemical Technology Co., Ltd.
| 4008-626-111 | 028-84752058 | sale@xiyashiji.com | CHINA |
9763
|
57
|
Hangzhou Yuhao Chemical Technology Co., Ltd
| +86-571-82693216/13216174607 | +86-571-82880190 | info@chemyuhao.com | CHINA |
9470
|
52
|
ShangHai YuanYe Biotechnology Co., Ltd.
| 021-61312847 qq:2797782341 | 021-60137357 | 2797782341@qq.com | CHINA |
7597
|
60
|
Shanghai LiuShi Pharmaceutical Technology Co., Ltd.
| 021-60135539 | 021-38721356 | shlschemical@hotmail.com | CHINA |
9967
|
55
|
T&W GROUP
| +86-21-61551611, 61551413, 61551420, 61551610 | +86-21-50676805 | contact@trustwe.com | CHINA |
13395
|
58
|
(CSR Factory)China Skyrun Industrial CO.,ltd
| info@chinaskyrun.com | manager@chinaskyrun.com | sales@chinaskyrun.com | CHINA |
12226
|
58
|
Cheng Du Micxy Chemical Co.,Ltd
| 028-85632863 028-64559668 18048500443 | 028-85632863 QQ: 2509670926 | micxysales@163.com | CHINA |
13240
|
58
|
|
|
|
|